Is there enough evidence to support the prognostic value of coronary physiology measurements in pre-and post-PCI settings? Is post-PCI FFR ready for clinical practice?

Today's episode features co-hosts Dr Peter Ong and Dr Andreas Seitz (Robert-Bosch Hospital, Stuttgart, DE) who together summarise the main results from the TARGET FFR and DEFINE-FLOW trials that were presented at TCT Connect 2020 and published recently in ECR journal, in the context of the existing literature:

Discussion summary includes:

- An examination of the trial background
- A summary of the trial design/methods
- A discussion around the trial results and their impact on practice

Prefer to watch in audio format? Click here.

Episodes are released on the first Friday of each month. If you have any questions, please email managingeditor@ecrjournal.com